HIGHLIGHTS
- who: Talea Knak and colleagues from the Institut fu00fcr Pharmazeutische und Medizinische Chemie, Heinrich Heine University Du00fcsseldorf, Universitu00e4tsstrau00dfe, Du00fcsseldorf, Germany have published the research: Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities, in the Journal: Pharmaceuticals 2022, 1553 of /2022/
- what: The study was discontinued for unknown reasons. The aim of this phase II study was to demonstrate the efficacy, tolerability and safety of the combination as a treatment of P. falciparum infections in both children and adults. The trial will be supporte 8 of 56 the EU Malaria Fund . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.